Categories
Automotive Lifestyle Professional Services Science Technology

ForA.Chat Launches Online Troubleshooting Mechanic Chatbot to Revolutionize the Auto Repair Industry

Vancouver, Canada – ForA.Chat is proud to announce the launch of their online troubleshooting mechanic chatbot, available at https://mechanic.fora.chat/. This new and innovative technology provides car owners with a fast, convenient, and expert solution for diagnosing and resolving common car problems.

With the increasing demand for quick and efficient auto repair services, ForA.Chat has developed an AI-powered chatbot that utilizes advanced natural language processing and machine learning algorithms to understand and interpret car problems and provide expert advice and recommendations. The chatbot is available 24/7, allowing car owners to get the help they need whenever they need it, without the need for a physical appointment.

“We’re thrilled to launch this cutting-edge technology that will revolutionize the auto repair industry,”. “Our online troubleshooting mechanic chatbot provides car owners with a fast, convenient, and expert solution for diagnosing and resolving common car problems. It’s an exciting time for ForA.Chat, and we’re proud to be at the forefront of this industry shift.”

The online troubleshooting mechanic chatbot is incredibly easy to use. Car owners simply launch the chatbot, describe their issue, and receive a response within minutes. The chatbot also offers a range of other useful features, such as the ability to schedule appointments, view service history, and receive reminders for important maintenance tasks. With ForA.Chat’s chatbot, car owners can manage all aspects of their vehicle’s health and well-being from the comfort of their own home.

“We’re committed to making car maintenance and repair as easy and convenient as possible,”. “Our chatbot is designed to provide an unparalleled level of convenience and support, and we’re confident that it will become a valuable tool for car owners everywhere.”

In conclusion, ForA.Chat’s online troubleshooting mechanic chatbot is the perfect solution for car owners who want quick and efficient assistance with their vehicles. With its advanced natural language processing and machine learning algorithms, 24/7 availability, and easy-to-use interface, ForA.Chat’s chatbot provides an unparalleled level of convenience and support.

To learn more about ForA.Chat’s online troubleshooting mechanic chatbot and start getting expert assistance for your car problems, visit https://mechanic.fora.chat/ today.

About ForA.Chat:

ForA.Chat is a leading provider of innovative technology solutions. With a commitment to customer satisfaction and a passion for innovation, ForA.Chat is dedicated to making car maintenance and repair as easy and convenient as possible.

Categories
Fitness Lifestyle Professional Services Science Technology

Revolutionary AI Helps Overcome Negative Thoughts

FOR IMMEDIATE RELEASE

A Revolutionary AI That Transforms Negative Thoughts and Shifts Your Perception

[Melbourne, Victoria] – We are thrilled to announce the launch of Grace, an Artificial Intelligence (AI) developed to help individuals shift their perspective and find the positive in any difficult situation. Grace is designed to reframe negative situations and provide a more optimistic outlook on life.

The idea for Grace was born out of the desire to harness the power of AI for good and to help humanity heal and grow. With the rise of AI and advancements in technology, the world is becoming increasingly complex and fast-paced. It can be easy to get caught up in negative thoughts and feelings. Grace offers a solution to this by providing a tool that helps individuals reframe their thoughts and find the silver lining in any situation.

Grace uses cutting-edge natural language processing and machine learning algorithms to understand the context of a statement and provide an optimistic response. This allows users to input any negative statement, and Grace will provide a positive reframe, helping to shift the user’s perspective.

“We are excited to introduce Grace to the world, as it offers a new way for individuals to manage their thoughts and emotions in a positive way,” said Rajiv Agarwal, the developer of Grace. “We believe that Grace has the potential to make a significant impact on mental health and overall well-being.”

Try it out for yourself and experience the power of positive reframing with Grace – https://seoauditing.com.au/ai/

Contact:

Rajiv Agarwal

beingisbliss@gmail.com

https://seoauditing.com.au

+61474567094

Categories
Building & Construction Electronics & Semiconductors Science Technology U.K

Process Parameters Releases Wiring Guide for the Pt100 Temperature Sensor

Process Parameters Ltd is a manufacturer of thermocouples, thermistor sensors and platinum resistance thermometers (also known as RTDs and Pt100s) with many years of experience.

The company is committed to meeting the needs of its customers and providing top-quality products. It provides products that are excellent value for money, backed by the highest levels of service and technical support from experts.

Process Parameters’s products are suitable for a various industries, such as aerospace, automotive, biomass, construction, defence, electronics, food & beverage, foundries, and more. The company’s product selection and specifications meet a wide range of needs over the entire temperature range (including cryogenic temperatures for molten metals).

The company’s wiring guide for Pt100 temperature sensors allows users to understand the wiring process since, according to UK-based industrial temperature sensor experts, a Pt100 temperature sensor’s conductor material depends on the thermocouple’s application.

A Pt100 temperature sensor has special wiring compared to other temperature sensors, particularly thermocouples. Therefore, incorrect sensor wiring could result in an inaccurate measurement or no reading from the measuring device.

According to Process Parameters Ltd’s wiring guide, a Pt100 temperature sensor will allow people to avoid mistakes during the wiring process. However, most people become confused over the misleading term “Pt100 Thermocouple”, as such a sensor type does not exist. Furthermore, this term combines the names of two technologies. Therefore, when specifying a thermocouple or Pt100, it is critical to identify the type of sensor in use.

Process Parameters Ltd states that a Pt100 is a sensor used to measure temperature. One type of sensor falls into a group called Resistance Temperature Detectors or RTDs. Several factors determine the specification of Pt100 temperature sensors, and what follows will describe each factor and allow you to specify a Pt100 temperature sensor easily.

Consequently, a guide for sensor wiring is crucial to ensure that wiring is done correctly. This is because the measuring instrument may give an incorrect or no reading.

The experts at Process Parameters have experience in providing temperature measurement, control, and recording solutions for various industries. Process Parameters Ltd has been involved in product selection and specification to fulfil various equipment over the whole temperature range, from cryogenic temperatures to molten metals.

By offering guides and advice on Pt100 temperature sensors, Process Parameters Ltd aims to make the wiring process as simple as possible. This will ensure the job is done right the first time.

Process Parameters Ltd. states that the circumstances of the process will determine the cable needed to connect the sensor to the measuring unit. Many standard sensors include a flying wire directly attached to the instrument. This cable was carefully chosen to satisfy the application’s temperature requirements and other environmental factors.

Process Parameters Ltd has been in business for over 14 years and serves many clients, from small businesses to large blue-chip companies and universities. Process Parameters Ltd’s discerning and well-trained staff have years of experience in industrial temperature measurement and thermography.

More information can be found at https://www.processparameters.co.uk.

Categories
Science Technology U.K

Geothermal Monitoring: Silixa Introduces its Latest Cost-Effective Solution for Long-Term Reservoir Monitoring

Hertfordshire, UK, 20th Jan — Silixa, the leading provider of fibre optic sensing-based data solutions, has recently brought its high-end geothermal monitoring solution—The Carina® GeoTH—into action. 

The company hopes that its Carina® GeoTH will act as a step-change in the long-term monitoring of geothermal reservoirs. 

“Carina® GeoTH is a reliable and proven continuous monitoring solution that delivers reliable information on microseismic, induced seismicity, and well integrity assessment,” explains a spokesperson from Silixa. “It provides reliable long-term reservoir monitoring.”

By enabling sustainable and economic utilisation of the Earth’s natural heat, Carina® GeoTH efficiently speeds up the energy transition. With this permanently installed integrated fibre optic system, Silixa is committed to providing clean, affordable energy.

Silixa’s class-leading geothermal monitoring solution delivers high-fidelity data essential to ensuring reliable reservoir monitoring, improving reservoir efficiency and safely deploying EGS.

By operating optimally even in corrosive and high-temperature environments, the Carina® GeoTH offers a continuous and simultaneous understanding of mechanical, thermal and hydraulic properties in a field.

The system offers highly accurate and precise data on reservoir simulation, reservoir deformation caused by temperature and pressure variations, reservoir temperature evolution, fracture networks, and more. 

Silixa’s high-end geothermal monitoring solution uses a single fibre optic cable as the sensing element that can be cemented behind the reservoir casing or installed in shallow geothermal systems.

It’s a highly flexible system with large coverage—Carina® GeoTH can deliver on-demand and continuous data over a large distance. 

Plus, having Silixa’s Carina® Sensing System as the underlying technology, the Carina® GeoTH enables operators to monitor multiple geothermal wells effectively using a single interrogator.

Due to the system involving no moving or electronic parts, the maintenance and operation costs decrease significantly.

On top of that, by operating autonomously in remote locations, Carina® GeoTH limits human intervention while also ensuring optimised geothermal operations. 

Silixa’s Carina® GeoTH helps technicians efficiently constrain permeable fracture zones. By leveraging active or passive seismic methods with a spectrum of automated surface sources, they can efficiently keep track of fracture behaviour and evolution in a geothermal field. 

Equipped with a high-end optoelectronics interrogator and high-temperature sensing cables, Silixa’s geothermal monitoring system enables simultaneous measurement of DAS, DSS, and DTS. 

The data collected in this integrated approach to geothermal monitoring facilitates numerical modelling of site fracture permeability as well as the validation of hydro-geomechanical simulations. The result is optimised EGS (Enhanced Geothermal System) resources and efficient drilling of subsequent injection/production wells. 

In addition, the high-resolution distributed strain, temperature, and acoustic sensing data delivered by Silixa offer the finest high-spatial resolution measurements in each 0.12 to 1.0 metres along the optical fibre cable. As a result, operators can gain reliable and in-depth insight into the geothermal reservoir. 

Furthermore, the integrated Edge Processing System with Silixa’s geothermal monitoring solution enables real-time visualisation and processing of these distributed strain, acoustic, and temperature data that facilitates decision-making. 

Founded in 2007, Silixa is committed to helping the mining, oil and gas, alternative energy, and environmental and earth sciences industries address critical measurement challenges with its high-end fibre-optic solutions. 

Interested parties can learn more about Silixa’s Carina® GeoTH by visiting https://silixa.com/sectors/energy/geothermal/.

Categories
Health & Medicine Pharmaceuticals & Biotech Science Technology U.S

Decentralization Plays a Key Role in Enhancing Oncological Care, Says ObvioHealth

New York, NY, Jan 20 — Leading Virtual research organization (VRO), ObvioHealth sheds light on the role of decentralized clinical trials(DCTs) in improving the quality of care for oncology patients.

“Extending the survivability of an illness is a key goal in the development of new medications, medical devices, and treatment protocols,” explains a spokesperson from ObvioHealth. “Increasing overall quality of care is an equally worthwhile objective. Incorporating DCT elements facilitates both goals.”

According to the VRO, conducting clinical trials is an effective way of improving the quality of life for cancer patients during and after treatment. However, clinical research in oncology isn’t reaching the patients who could benefit the most. 

Even though the barriers to clinical trial participation have been a topic of frequent research, no subsequent policy changes have shifted the paradigm enough to vastly change trial participation rates over time.  

Case in point: Clinical barriers (e.g., not meeting eligibility criteria) and structural barriers (e.g., the absence of an available clinical trial, travel cost, etc.) make trial participation unachievable for more than three-quarters of oncology patients, according to a study published in the Journal of the National Cancer Institute. 

For cancer patients with rare, irremediable, or life-threatening physical conditions, DCT designs can bring new care options by increasing their access to innovative therapeutics. 

However, due to having logistic constraints, full decentralization is not feasible for some types of clinical trials in the oncology space. 

Delivering drugs to a patient’s home, maintaining drug stability, and hiring certified nurses to administer drugs to patients at home are some of the constraints to oncology trial decentralization. 

Despite these hurdles, adopting DCT elements through hybrid trial models is rapidly gaining momentum. 

As a more patient-centric approach to oncology trials, DCTs can streamline trial processes while also significantly enhancing trial logistics. 

A DCT’s potential to facilitate access by eliminating geographic barriers to entry is a game-changer for cancer research and treatment. With DCTs in place, local oncologists can refer patients to trial screenings without overwhelming a small community hospital that can’t support centralized research.

The VRO highlights DCT and hybrid clinical studies as the way forward to reduce patient burden in oncology trials. 

Even though much of oncology research still requires on-site participation, specific appointments are more administrative than interventional and don’t need the one-on-one involvement of a physician.

Allowing participants to volunteer for trials from the comfort of their homes, DCTs minimize the need for in-person visits, thus decreasing patient burden substantially.

In addition, participants’ reluctance to report symptoms or hesitation to contact their trial support staff if they develop side effects can impact data quality and ultimately, the accuracy of trial endpoints. 

DCT solutions include convenient in-app messaging tools that help patients communicate with physicians and flag symptoms that they might otherwise consider insignificant.

On top of this, by enabling real-time reporting and communication, DCT solutions drive data quality and allow study teams to make evidence-based, data-driven decisions around the effect of a treatment on a participant’s quality of life.

Instead of capturing a brief snapshot of a patient’s health during a clinical visit, DCT solutions enable study teams to gain a longitudinal view of how their patients’ health may be trending. Continuous monitoring of risk factors, health outcomes, or both, based on the symptoms logged by patients with ePRO, helps sponsors make data-driven decisions about patient care.

To navigate challenges to success and extend access to life-improving treatments for cancer patients, adopting the modular approach (e.g., leveraging digital questionnaires or online recruitment) to oncology trials is critical, explains ObvioHelath.

Headquartered in New York, NY, ObvioHealth is a global digital health company committed to driving innovation in healthcare. With its tech-enabled nextGen DCT platforms, ObvioHelath helps sponsors effortlessly produce robust therapeutic evidence. 

Interested parties can find more information about ObvioHealth by visiting https://www.obviohealth.com

Categories
Computers & Software Science Technology U.S

Sapio Sciences Rings in 2023 With Major Investment from GHO Capital

Baltimore, MD, Jan 6, 2023 — The London-based leading specialist healthcare investment advisor, Global Healthcare Opportunities, also called GHO Capital Partners LLP, has announced its investment in Sapio Sciences, a high-growth integrated lab informatics platform.

Lab informatics platforms are gaining momentum today, with more modern laboratories striving to accelerate their R&D. With GHO’s backing to scale it, Sapio Sciences hopes the company will evolve as a formidable player in the lab informatics market. 

Kevin Cramer, Chief Scientist and CEO at Sapio, said of GHO’s recent investment decision, “As lab workflows become increasingly complex and the volume of data increases, the management, and interrogation of that data becomes even more vital. Over the last eighteen years, Sapio has built a uniquely flexible, scalable, unified, and easy-to-use informatics platform developed specifically to address the deficiencies of current processes. We are proud to have GHO partner with us to support our next transformational steps as a company.”

Launched in 2004, Sapio Sciences is a US-based state-of-the-art lab informatics platform committed to transforming and speeding up life science R&D for biopharma, CROs, and clinical labs. 

This unified low-code/no-code platform offers various lab software products, such as its high-end scalable Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Software Data Management (SDMS) software.

Sapio helps digital labs address all challenges they face while breaking through data silos and driving efficiency in their laboratory operations.

Sapio’s collaborative LIMS system allows multiple researchers to work on the same workflow simultaneously while also enabling rapid implementation of their workflow processes.

It’s the only informatics platform that provides digital labs with integrated ELN, LIMS, and SDMS with powerful data capture and searching tools.

Allowing laboratories to centralize data once siloed in multiple systems and making them effortlessly searchable and shareable among departments, Sapio streamlines the scientific discovery process.

With Sapio LIMS’s fully configurable technology and workflow templates, projects can be accomplished in a fraction of the time and cost of a standard lab management project. 

Validated by a broad and loyal customer base, including blue-chip companies across the USA with additional footholds in Japan and Europe, Sapio continues to help drive innovation in the ever-evolving lab informatics and pharmaceutical landscape. 

GHO’s investment, combined with its unrivaled experience, will support Sapio to drive growth for the company while facilitating its product development, says the private equity firm.

In addition, the firm’s investment into Sapio’s Commercial function and Business Development will help it establish a go-to-market strategy, thus uncovering significant white space in the market. 

To quote the Partners at GHO Capital, “The trend towards adopting lab informatics solutions is accelerating. Sapio represents a perfect opportunity to support a high-growth, profitable company with a uniquely scalable SaaS business model, operating in attractive markets that are underpenetrated and desperate for innovation. Working in lockstep with Kevin, we look forward to building upon Sapio’s best-in-class profile and unlocking the multiple expansion opportunities to scale up and internationalize the business, delivering life-changing products to market faster.”

Backed by eighteen years of experience, Sapio Sciences continues to remain a trusted and unbiased partner to its global clientele. 

Interested parties can learn more about Sapio Sciences by visiting https://www.sapiosciences.com

Categories
Health & Medicine Pharmaceuticals & Biotech Science

SEFUNDA, LLC announces the Launch of their Crowdfunding Campaign

Sefunda, a Swiss based company established in early 2019, is a small, dedicated team of professionals with background in IVD product development, molecular epidemiology, medical device development and material science combined with business strategy and experience with well more than 100 years.

OUR MISSION:

Increase the safety of patients, reduce individual healthcare costs, promote antibiotic stewardship. 

We are all about finding the solution to a problem – using technology as a tool and not a purpose. We are a dedicated lean team of experienced professionals combining Swiss precision with creativity and visionary drive. Listening to real market needs, we understand the economics driving the health care sector and the intricacies of producing high volume consumables at low and affordable cost.

THE KEY PROBLEM:

Recent research shows that 30% – 50% of patients in the US receive incorrect antimicrobial treatment This can in part be attributed to inefficient or incorrect diagnostic processes. Even for the most common infections, the delay between testing and effective treatment can take up to 10 days.

OUR SOLUTION:

We make patient-tailored treatment truly accessible and affordable for everybody – delivering immediate actionable results for treatment decision where time matters most. Our rapid, cost-effective and easy to use testing platform empowers health care professionals to diagnose and treat patients within one single visit, normally less than 30 minutes. By combining robust, proven and adaptable technology with smart multiplexing capabilities, we bring the precision of a molecular diagnostics lab to your office.

WHAT SETS US APART?

We focus on the solution, not the technology. By building on robust and proven technology, we avoid «reinventing the wheel» and save money and time. Together with our American partner Tensentric, Boulder Co., Sefunda is building a business ecosystem, that enables us to build a cost effective, low barrier molecular diagnostics solution. A small, powerful team is building a PCR based molecular diagnostics solution, that is going to bring laboratory quality molecular diagnostics to your local clinic. Trade Secret agreements will keep the development from competitors copying our solution much longer than any IP.

CLIA waiver as door opener for the US market:

Background: The Clinical Laboratory Improvement Amendments of 1988 (CLIA) enabled greater access to low-risk tests by allowing their use in facilities with a Certificate of Waiver in the U.S. Recently, the 2019 novel coronavirus (COVID-19) pandemic has shined a spotlight on CLIA-waived diagnostic testing. To meet this increased patient demand for diagnostic testing, the U.S. Department of Health and Human Services (HHS) authorized licensed pharmacists to order and administer FDA authorized COVID-19 tests.

Financial Overview:

Below is the financial overview assuming one product, roll-out in late 2023, a market share of 3%, sales within the US only. We will be adding a second product in early 2024. Estimated exit value in 2024 is around US$100mio. 

*: estimates based under current US market conditions and known regulatory US environment.   

Total Projected Cost:  

Total estimated costs before getting cash positive in 2024 are expected to be approximately: US$35,000,000 US Dollar. 

SEFUNDA, LLC is committed to obtaining and providing the monies necessary to institute and complete this project in a timely manner. 

SEFUNDA, LLC Equity Crowdfunding Campaign, 

https://www.equitynet.com/c/sefunda-llc

Categories
Science Technology

Nobel Prize in Physics Recognizes Black Hole Discoveries

COLLEGE PARK, MD, October 6, 2020 — The Royal Swedish Academy of Sciences has awarded the 2020 Nobel Prize in Physics to Roger Penrose “for the discovery that black hole formation is a robust prediction of the general theory of relativity” and to Reinhard Genzel and Andrea Ghez “for the discovery of a supermassive compact object at the centre of our galaxy.” Ghez is the fourth woman to win a Nobel Prize in Physics.

“APS congratulates the 2020 Nobel Laureates for their outstanding contributions to astrophysics, and the understanding of our universe,” said APS CEO Kate Kirby. “I sincerely hope that this award will inspire the next generation of physicists, especially young women, whom we are committed to supporting at every level.”

“I’m pleased to see the Swedish academy recognize a fourth woman Nobel Laureate,” said APS President Phil Bucksbaum. “Andrea Ghez joins Donna Strickland, Maria Goeppert Mayer, and Marie Curie as the only women with that distinction.”

Nobel Prize 2020 winners photo

Niklas Elmehed (c) Nobel Media

Half of the prize goes to the University of Oxford’s Penrose, whose research published in Physical Review Letters during the 1960s is considered the most important contribution to the general theory of relativity since its conception by Albert Einstein more than a century ago. In 1971, APS and the American Institute of Physics honored Penrose with the Dannie Heineman Prize for Mathematical Physics.

The other half of the prize is jointly awarded to Genzel and Ghez, both APS Fellows, who have provided some of the strongest evidence to date that the compact object at the center of the Milky Way known as Sagittarius A* is very likely a supermassive black hole. Genzel gave an invited talk at the 2020 APS April Meeting where he described the culmination of nearly 30 years of observations of the star S2, revealing that it orbits Sagittarius A* just as Einstein predicted, in the shape of a rosette rather than an ellipse. Genzel is co-director of the Max Planck Institute for Extraterrestrial Physics and professor emeritus at the University of California, Berkeley.

Glennys Farrar, chair of the APS Division of Astrophysics, said: “I’m thrilled that the Nobel Committee has recognized the critical importance of the work of Genzel and Ghez, which established beyond a doubt the existence of a supermassive black hole at the center of the Milky Way, and the work of Penrose with Stephen Hawking, predicting the existence of black holes.”

“Their work has made pioneering use of adaptive optics on the Keck telescope, and it has led to the understanding that supermassive black holes inhabit the centers of many galaxies,” said Bucksbaum.

APS recognized Ghez, a professor of astrophysics at the University of California, Los Angeles, early in her career with the 1999 Maria Goeppert Mayer Award for outstanding achievement by a woman in physics. She presented an overview of decades of research on the Galactic Center at a plenary session at the 2019 April Meeting in Denver, CO.

“As often happens in science, a conceptual breakthrough relies on developing powerful new tools, which then lead to other discoveries,” said Farrar. “The precise measurements of the Genzel and Ghez teams have not only verified aspects of General Relativity that had never before been tested, but have also led to much more accurate knowledge of the location of the Solar System in the Galaxy which will be valuable in many other applications.”

“For science to advance requires unbounded leaps of imagination, but such leaps must be subject to rigorous observational examination,” said APS President-Elect Sylvester James Gates, Jr. “So we see two dichotomies, both Illustrated in this Nobel Prize, with Penrose’s work as an example of the first while the work of Genzel and Ghez illustrate the latter.”

This is the tenth consecutive year Physical Review Letters, the flagship journal of the American Physical Society, has been cited in the scientific background materials of the physics or chemistry prizes. A recent analysis revealed that, since 1995, 28.5% of Nobel-winning research in physics appeared in Physical Review Letters, outpacing other leading publications such as The Astrophysical Journal (11.2%), Science (5.6%), and Nature (4.7%).

Journals Nobel 2020 chart

“The Physical Review journals are among the most-read and highest-cited peer-reviewed publications in physics and related disciplines, broadly trusted and valued by researchers around the world for more than 127 years,” said APS Publisher Matthew Salter.

The Nobel Prize, first awarded in 1901, is widely regarded as the highest honor in science, economics, and literature. Due to the ongoing COVID-19 pandemic, the 2020 award ceremony at Stockholm City Hall will be streamed online in December. Laureates will receive medals and diplomas in their home countries. The Nobel Foundation has increased the prize amount to 10 million Swedish krona (about 1.1 million US dollars) for the first